KI-Beratung Beta

Produktbild: Commercial Plant-Produced Recombinant Protein Products
Band 68

Commercial Plant-Produced Recombinant Protein Products Case Studies

Fr. 137.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Attention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that...

Beschreibung

Attention has recently turned to using plants as hosts for the production of commercially important proteins. The twelve case studies in this volume present successful strategies for using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They examine in detail projects that have commercial potential or products that have already been commercialized, illustrating the advantages that plants offer over bacterial, fungal or animal cell-culture hosts. There are many indications that plant protein production marks the beginning of a new paradigm for the commercial production of proteins that, over the next decade, will expand dramatically.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.08.2016

Abbildungen

XII, 281 p. 33 illus., 17 illus. in color.

Herausgeber John A. Howard + weitere

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.08.2016

Abbildungen

XII, 281 p. 33 illus., 17 illus. in color.

Herausgeber
Verlag Springer Berlin
Seitenzahl

281

Maße (L/B/H)

23.5/15.5/1.7 cm

Gewicht

452 g

Auflage

Softcover reprint of the original 1st edition 2014

Sprache

Englisch

ISBN

978-3-662-52295-0

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Commercial Plant-Produced Recombinant Protein Products
  • Introduction — Plant-produced protein products.- Commercial Plant-Produced Recombinant Avidin.- Molecular farming in plants – the long road to the market.- TrypZean™: an animal-free alternative to bovine trypsin.- Production of Pharmaceutical Grade Recombinant Native Aprotinin and Non-Oxidized Aprotinin-Variants Under Greenhouse and Field Conditions.- Influenza virus-like particles produced in Nicotiana benthamiana protect against a lethal viral challenge in mice.- Plant-Produced Recombinant Transmission Blocking Vaccine Candidates to Combat Malaria.- An oral vaccine for TGEV immunization of pigs.- Edible Rabies Vaccines.- Newcastle disease vaccines.- An oral vaccine for hepatitis B: challenges, setbacks and breakthroughs.- Commercial Plant-Produced Recombinant Cellulases for Biomass Conversion.- Brazzein: A High Intensity Natural Sweetener.- The Future of Plant-Produced Pharmaceuticals and Industrial Proteins.